Supernus Pharmaceuticals Inc
LSE:0LB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
LSE:0LB2
|
US |
Wall St Price Targets
0LB2 Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 0LB2 is 65.81 USD with a low forecast of 57.04 USD and a high forecast of 71.16 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0LB2's stock price target?
Price Target
65.81
USD
According to Wall Street analysts, the average 1-year price target for 0LB2 is 65.81 USD with a low forecast of 57.04 USD and a high forecast of 71.16 USD.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 59%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
205%
The compound annual growth rate for Operating Income over the next 3 years is 205%.
